High Multiple

Veterinary Diagnostics Business — Business Valuation Multiple

EBITDA Valuation Guide · Small & Mid-Sized Businesses

Actual EBITDA multiples can vary materially based on EBITDA size, growth, recurring revenue, margins, customer concentration, owner dependence, geography and other company-specific factors.

Min

5×

Typical

7×

Max

9×

Revenue Model

Repeat

Capital Intensity

High

5×Typical EBITDA Range9×

A typical multiple of 7× EBITDA reflects mid-market transactions in the $1–$50M revenue range.

Overview

Veterinary diagnostics businesses — including pathology labs, imaging, and point-of-care diagnostics — typically trade at 5×–9× EBITDA. Recurring referral income from veterinary practices, proprietary diagnostic platform or reagent income, and consolidator appetite in the animal health sector support premium valuations. Skilled laboratory staff recruitment and equipment capital intensity are the primary risk factors.

Key Value Drivers

  • Recurring referral income from vet practices
  • Proprietary diagnostic platform or reagent income
  • Accreditation and quality management
  • Consolidator demand in animal health
  • 24/7 emergency pathology capability

Key Risks

  • Skilled laboratory staff recruitment
  • Equipment capital intensity and calibration
  • Vet practice client concentration
  • Regulatory standards and accreditation
  • Diagnostic technology refresh cycles

Disclaimer: All multiples are indicative estimates only and are not formal valuations or investment advice. They should not be relied upon for financial decision-making without independent professional advice.